Symbols / ALF Stock $10.84 +0.00% Centurion Acquisition Corp.
ALF (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Centurion Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Centurion Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Ratings
Current target
$10.84
Low
—
High
—
Mean
—
News
RSS: Latest ALF news- Goldman Sachs (ALF) discloses 1,036,238 shares, 3.6% stake in Centurion - Stock Titan Mon, 11 May 2026 17
- Alfresa Holdings Corp stock (JP3122800000): Earnings preview ahead of May 15 report - AD HOC NEWS hu, 14 May 2026 08
- Centurion Acquisition (ALF) earns $2.5M interest income but flags going concern risk - Stock Titan Mon, 11 May 2026 20
- TradingKey - TradingKey ue, 12 May 2026 20
- ALFTAQA Stock Price and Chart — KSE:ALFTAQA - TradingView ue, 16 Dec 2025 08
- Insider Sell: Alf Melin Sells 127,275 Shares of TechnipFMC PLC (FTI) - GuruFocus Wed, 11 Mar 2026 07
- [PRER14A] Centurion Acquisition Corp. Preliminary Revised Proxy Statement - Stock Titan Mon, 11 May 2026 21
- symbol__ Stock Quote Price and Forecast - CNN hu, 13 Jun 2024 02
- ALFUU SEC Filings - Centurion Acquisition Corp. 10-K, 10-Q, 8-K Forms - Stock Titan Mon, 11 May 2026 20
- ALF Forecast — Price Prediction for 2026. Should I Buy ALF? - Intellectia AI Mon, 12 May 2025 01
- Goldman Sachs Group Inc's Strategic Acquisition of Centurion Acq - GuruFocus Sun, 17 Aug 2025 07
- Alfi Stock Price Forecast. Should You Buy ALF? - StockInvest.us Fri, 28 May 2021 12
- Brazil’s Stock Market Had a Knockout Year. More Gains Hinge on Political Change. - Barron's ue, 23 Dec 2025 08
- Second DMD Patient Dies After Treatment with Sarepta Gene Therapy - Genetic Engineering and Biotechnology News Sun, 15 Jun 2025 07
- Medical examiner shares former 'ALF' star Benji Gregory's cause of death - Yahoo Fri, 13 Sep 2024 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
| Operating Expense |
|
0.63
+33.96%
|
0.47
|
| Other Operating Expenses |
|
0.63
+33.96%
|
0.47
|
| Total Expenses |
|
0.63
+33.96%
|
0.47
|
| Operating Income |
|
-0.63
-33.96%
|
-0.47
|
| Total Operating Income As Reported |
|
-0.63
-33.96%
|
-0.47
|
| EBITDA |
|
-0.63
-33.96%
|
-0.47
|
| Normalized EBITDA |
|
-0.63
-33.96%
|
-0.47
|
| EBIT |
|
-0.63
-33.96%
|
-0.47
|
| Net Income |
|
11.74
+49.80%
|
7.84
|
| Pretax Income |
|
11.74
+49.80%
|
7.84
|
| Net Non Operating Interest Income Expense |
|
12.37
+48.91%
|
8.31
|
| Net Interest Income |
|
12.37
+48.91%
|
8.31
|
| Interest Income Non Operating |
|
12.37
+48.91%
|
8.31
|
| Interest Income |
|
12.37
+48.91%
|
8.31
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
11.74
+49.80%
|
7.84
|
| Net Income From Continuing Operation Net Minority Interest |
|
11.74
+49.80%
|
7.84
|
| Net Income From Continuing And Discontinued Operation |
|
11.74
+49.80%
|
7.84
|
| Net Income Continuous Operations |
|
11.74
+49.80%
|
7.84
|
| Normalized Income |
|
11.74
+49.80%
|
7.84
|
| Net Income Common Stockholders |
|
11.74
+49.80%
|
7.84
|
| Diluted EPS |
|
—
|
0.33
|
| Basic EPS |
|
—
|
0.33
|
| Basic Average Shares |
|
—
|
23.52
|
| Diluted Average Shares |
|
—
|
23.52
|
| Diluted NI Availto Com Stockholders |
|
11.74
+49.80%
|
7.84
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Assets |
|
308.34
+3.94%
|
296.66
|
| Current Assets |
|
0.16
-79.86%
|
0.80
|
| Cash Cash Equivalents And Short Term Investments |
|
0.10
-84.82%
|
0.67
|
| Cash And Cash Equivalents |
|
0.10
-84.82%
|
0.67
|
| Cash Financial |
|
0.10
-84.82%
|
0.67
|
| Prepaid Assets |
|
0.06
-55.10%
|
0.13
|
| Total Non Current Assets |
|
308.17
+4.16%
|
295.86
|
| Non Current Prepaid Assets |
|
0.00
-100.00%
|
0.05
|
| Other Non Current Assets |
|
308.17
+4.18%
|
295.81
|
| Total Liabilities Net Minority Interest |
|
13.75
-0.47%
|
13.81
|
| Current Liabilities |
|
0.06
-51.61%
|
0.12
|
| Payables And Accrued Expenses |
|
0.05
-52.69%
|
0.11
|
| Payables |
|
0.05
-52.69%
|
0.11
|
| Accounts Payable |
|
0.05
-55.09%
|
0.11
|
| Current Deferred Liabilities |
|
0.01
-39.19%
|
0.01
|
| Total Non Current Liabilities Net Minority Interest |
|
13.69
+0.00%
|
13.69
|
| Tradeand Other Payables Non Current |
|
13.69
+0.00%
|
13.69
|
| Stockholders Equity |
|
294.59
+4.15%
|
282.84
|
| Common Stock Equity |
|
294.59
+4.15%
|
282.84
|
| Capital Stock |
|
308.17
+4.18%
|
295.81
|
| Common Stock |
|
308.17
+4.18%
|
295.81
|
| Preferred Stock |
|
0.00
|
0.00
|
| Share Issued |
|
35.94
+0.00%
|
35.94
|
| Ordinary Shares Number |
|
35.94
+0.00%
|
35.94
|
| Additional Paid In Capital |
|
0.00
|
0.00
|
| Retained Earnings |
|
-13.59
-4.83%
|
-12.96
|
| Total Equity Gross Minority Interest |
|
294.59
+4.15%
|
282.84
|
| Total Capitalization |
|
294.59
+4.15%
|
282.84
|
| Working Capital |
|
0.10
-85.10%
|
0.67
|
| Invested Capital |
|
294.59
+4.15%
|
282.84
|
| Net Tangible Assets |
|
294.59
+4.15%
|
282.84
|
| Tangible Book Value |
|
294.59
+4.15%
|
282.84
|
| Dueto Related Parties Current |
|
0.01
+0.00%
|
0.01
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Cash Flow |
|
-0.56
-241.57%
|
-0.17
|
| Cash Flow From Continuing Operating Activities |
|
-0.56
-241.57%
|
-0.17
|
| Net Income From Continuing Operations |
|
11.74
+49.80%
|
7.84
|
| Other Non Cash Items |
|
—
|
0.34
|
| Operating Gains Losses |
|
-12.37
-50.26%
|
-8.23
|
| Gain Loss On Investment Securities |
|
-12.37
-50.26%
|
-8.23
|
| Unrealized Gain Loss On Investment Securities |
|
0.00
+100.00%
|
-0.07
|
| Change In Working Capital |
|
0.06
+280.55%
|
-0.03
|
| Change In Prepaid Assets |
|
0.13
+179.18%
|
-0.16
|
| Change In Payables And Accrued Expense |
|
-0.06
-152.69%
|
0.11
|
| Change In Payable |
|
-0.06
-152.69%
|
0.11
|
| Change In Account Payable |
|
-0.06
-155.09%
|
0.11
|
| Change In Other Current Liabilities |
|
-0.00
-139.19%
|
0.01
|
| Investing Cash Flow |
|
0.00
+100.00%
|
-287.50
|
| Cash Flow From Continuing Investing Activities |
|
0.00
+100.00%
|
-287.50
|
| Net Other Investing Changes |
|
—
|
-287.50
|
| Financing Cash Flow |
|
0.00
-100.00%
|
288.33
|
| Cash Flow From Continuing Financing Activities |
|
0.00
-100.00%
|
288.33
|
| Net Issuance Payments Of Debt |
|
0.00
+100.00%
|
-1.11
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-1.11
|
| Short Term Debt Payments |
|
0.00
+100.00%
|
-1.11
|
| Net Short Term Debt Issuance |
|
0.00
+100.00%
|
-1.11
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
282.50
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
7.00
|
| Net Other Financing Charges |
|
—
|
-0.06
|
| Changes In Cash |
|
-0.56
-184.82%
|
0.67
|
| Beginning Cash Position |
|
0.67
|
0.00
|
| End Cash Position |
|
0.10
-84.82%
|
0.67
|
| Free Cash Flow |
|
-0.56
-241.57%
|
-0.17
|
| Common Stock Issuance |
|
0.00
-100.00%
|
282.50
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
282.50
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|